| 30-May-2019 | D | Kilitch Drugs India Ltd has informed BSE that the Board of Directors of the Company at its Meeting held on May 30, 2019, inter alia, have recommended a final dividend of Re. 0.50/- per equity share (face value of Rs. 10/- each) for the financial year 2018-19, subject to the approval of the Members at the ensuing Annual General Meeting ('AGM') of the Company. The dividend, if approved by the Members shall be paid within 30 days from the date of AGM. | 20-Sep-2019 | |
| 25-May-2018 | D | Kilitch Drugs India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 25, 2018, in alia , has recommended a final dividend of Re. 0.50 per Equity Share ( Face Value of Re. 10/- each) for the year ended 31st March, 2018. This dividend upon approval by the shareholders at the ensuing Annual General Meeting (AGM) will be paid within 30 days from the date of AGM. | 18-Sep-2018 | |
| 30-Aug-2012 | D | Kilitch Drugs India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 30, 2012, inter alia,
1. Declared Special Interim dividend @ 300% (i.e. Rs.30/- per equity share of Rs.10/- each) on the equity shares of the Company. | 24-Sep-2012 | |
| 25-Jul-2011 | D | Kilitch Drugs India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on July 25, 2011, inter alia, has:
1. Recommended dividend @ 10% [i.e. Re. 1/- per equity share of Rs. 10/- each] on the equity shares of the Company, subject to the approval of the Members at the ensuing 19th Annual General Meeting; | 18-Aug-2011 | |
| 16-Sep-2010 | D | Kilitch Drugs India Ltd has now informed BSE that the Board of Directors at their meeting held on August 10, 2010 had recommended the dividend of Rs. 1/- (10%) on Rs. 10/- per share on 13202122 equity shares of Rs. 10/- each aggregating to Rs. 13202122/- subject to the approval of the members at the forthcoming 18th Annual General Meeting which is scheduled to be held on September 20, 2010. | 14-Oct-2010 | |
| 03-Jul-2009 | D | Kilitch Drugs India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 30, 2009, inter alia, has recommended dividend @ 10% for the financial year 2008-09 subject to approval of the members at the ensuing Annual General Meeting of the Company. | 10-Sep-2009 | |
| 23-Jun-2008 | D | Kilitch Drugs India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 21, 2008, inter alia, has recommended a Final Dividend of 10% on the Equity Share Capital, subject to approval by Shareholders. Thus, if approved, the total dividend, inclusive of the interim dividend, for the year would aggregate to 20%. | 10-Sep-2008 | |
| 02-Nov-2007 | D | Kilitch Drugs India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 31, 2007, inter alia, has declared Interim Dividend @ 10% per share of the Company. | 15-Nov-2007 | |
| 04-Nov-2024 | BC | KILITCH DRUGS (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 inter alia to consider and approve unaudited Financial Results (Standal | 12-Nov-2024 | |
| 26-Aug-2024 | BC | Notice of 32' Annual General Meeting of the Company for the financial year ended 31
March, 2024 to be convened and held on Friday, 27' September, 2024 at 9:30 am through video conferencing and other | 27-Sep-2024 | |
| 26-Aug-2024 | BC | Pursuant to regulation 42 of the SEBI (Listing Obligation and Disclosure Requirements)
Regulations, 2015, the Register of Members and Share Transfer Books of the Company
shall remain closed from Fr | 20-Sep-2024 | |
| 30-Aug-2024 | BC | Pursuant to Regulation 30 of SEBI LODR Regulations, this is to inform you that the Board of Directors approved the appointment of M/s C Sharat & Company, Chartered Accountants as a Statutory Auditors | 30-Aug-2024 | |
| 26-Aug-2024 | BC | Appointment of Mr. Dipen Jayantilal Jain (DIN: 01148262) as an Additional Director
(Non-executive, Independent) with effect from 27' August, 2024, subject to member's
approval at ensuing AGM. Brief | 27-Aug-2024 | |
Announcement Date30-May-2019
Ex Dividend Date20-Sep-2019
Dividend(%)5
Announcement Date25-May-2018
Ex Dividend Date18-Sep-2018
Dividend(%)5
Announcement Date30-Aug-2012
Ex Dividend Date24-Sep-2012
Dividend(%)300
Announcement Date25-Jul-2011
Ex Dividend Date18-Aug-2011
Dividend(%)10
Announcement Date16-Sep-2010
Ex Dividend Date14-Oct-2010
Dividend(%)10
Announcement Date03-Jul-2009
Ex Dividend Date10-Sep-2009
Dividend(%)10
Announcement Date23-Jun-2008
Ex Dividend Date10-Sep-2008
Dividend(%)10
Announcement Date02-Nov-2007
Ex Dividend Date15-Nov-2007
Dividend(%)10
No Bonus has been declared by KILITCH
No Split has been declared by KILITCH
RightsNo Rights has been declared by KILITCH
Book Closure
| 12-Nov-2024 | - | KILITCH DRUGS (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 inter alia to consider and approve unaudited Financial Results (Standal |
| 27-Sep-2024 | - | Notice of 32' Annual General Meeting of the Company for the financial year ended 31
March, 2024 to be convened and held on Friday, 27' September, 2024 at 9:30 am through video conferencing and other |
| 20-Sep-2024 | 01 Jan'1900 | Pursuant to regulation 42 of the SEBI (Listing Obligation and Disclosure Requirements)
Regulations, 2015, the Register of Members and Share Transfer Books of the Company
shall remain closed from Fr |
| 30-Aug-2024 | - | Pursuant to Regulation 30 of SEBI LODR Regulations, this is to inform you that the Board of Directors approved the appointment of M/s C Sharat & Company, Chartered Accountants as a Statutory Auditors |
| 27-Aug-2024 | - | Appointment of Mr. Dipen Jayantilal Jain (DIN: 01148262) as an Additional Director
(Non-executive, Independent) with effect from 27' August, 2024, subject to member's
approval at ensuing AGM. Brief |